Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infection-Reference-Cited by-同舟云学术

Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infection

Published:2010-03-22 Issue:8 Volume:30 Page:1241-1242
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Matsumoto Tomonori,Marusawa Hiroyuki,Dogaki Miki,Suginoshita Yoshiki,Inokuma Tetsuro

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2010.02238.x/fullpdf

Reference8 articles.

1. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy;Hui;Gastroenterology,2006

2. Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen;Marusawa;J Gastroenterol,2001

3. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period;Iwai;Bone Marrow Transplant,2000

4. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients;Zingarelli;reports of 3 cases and review of the literature,2009

5. Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient;Montiel;Liver Int,2008

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Recombinant human type II tumour necrosis factor receptor-antibody fusion protein induced occult hepatitis B virus reactivation leading to liver failure;Journal of International Medical Research;2024-05

2. Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation;Dermatology;2023-11-14

3. Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy;Digestive Diseases and Sciences;2023-10-27

4. Risk of hepatitis B reactivation in patients receiving anti‐tumor necrosis factor‐α therapy;International Journal of Rheumatic Diseases;2020-11-27

5. Updates on management strategies of hepatitis B virus reactivation in patients with resolved hepatitis virus B infection undergoing immunosuppressive therapy in rheumatology and the current situation in Niigata Rheumatic Center;Modern Rheumatology;2020-10-29